Trademark: 87710789
Word
C COMPREHENSIVE CELL SOLUTIONS
Status Date
Tuesday, October 2, 2018
Registration Number
5573697
Registration Date
Tuesday, October 2, 2018
Filing Date
Wednesday, December 6, 2017
Published for Opposition
Tuesday, July 17, 2018
40 Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, cryopreservation of human cells
39 Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, storage of blood and stem cells
5 Products to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, blood plasma, blood for medical purposes, blood products for medical and clinical trial use, antibody positive plasma, phenotyped red cell units, monoclonal antibodies to RBC antigens, cord blood; mononuclear cells, progenitor cells, antibody preparations for use in medical clinical trials, research and medical purposes
35 Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, providing independent review of clinical trials for business purposes
44 Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, tissue bank services; cell processing services for use by others; stem cell storage; collection and preservation of human blood, apheresis, red blood cells, plasma and bone marrow
42 Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, medical laboratory, pharmaceutical research services and pharmaceutical clinical trials for others
The mark consists of the terms "COMPREHENSIVE CELL SOLUTIONS" in dark blue text with gray shadowing, positioned to the right of a stylized letter "C". The stylized letter "C" is divided into four segments, changing from light blue to dark blue from top to bottom. Solid bubbles surround the "C" also in the same light blue and dark blue radiating from each segment.
The color(s) light blue, dark blue and gray is/are claimed as a feature of the mark.
"COMPREHENSIVE CELL SOLUTIONS"
Oct 2, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Oct 2, 2018
Registered-Principal Register
Jul 17, 2018
Official Gazette Publication Confirmation E-Mailed
Jul 17, 2018
Published For Opposition
Jun 27, 2018
Notification Of Notice Of Publication E-Mailed
Jun 4, 2018
Approved For Pub - Principal Register
May 29, 2018
Teas/Email Correspondence Entered
May 29, 2018
Correspondence Received In Law Office
May 29, 2018
Teas Response To Office Action Received
Mar 20, 2018
Notification Of Priority Action E-Mailed
Mar 20, 2018
Priority Action E-Mailed
Mar 20, 2018
Priority Action Written
Mar 15, 2018
Previous Allowance Count Withdrawn
Mar 15, 2018
Approved For Pub - Principal Register
Mar 13, 2018
Assigned To Examiner
Dec 19, 2017
Notice Of Design Search Code E-Mailed
Dec 17, 2017
New Application Office Supplied Data Entered
Dec 9, 2017
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
